Wang Xiaodong
Director at BGNE
- Sold, on record
- $165M
- Dollars the filings state
- Form 4 sales
- 49
- Latest Sep 28, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BGNEBeiGene, Ltd.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BGNERoutineMar 4 2025
Sold 8,146 shares at $254.58 ($2.1M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($2.1M position)0 shares left0.2x usual sizeFiling
- 2 Form 4 sale BGNERoutineMar 18 +14 days
Sold 41,760 shares at $261.29 ($10.9M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($10.9M position)0 shares left1x usual sizeFiling
- 3 Form 4 sale BGNERoutineApr 14 +27 days
Sold 41,760 shares at $242.66 ($10.1M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($10.1M position)0 shares left1x usual sizeFiling
- 4 Form 4 sale BGNERoutineMay 13 +29 days
Sold 41,760 shares at $223.50 ($9.3M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($9.3M position)0 shares left1x usual sizeFiling
- 5 Form 4 sale BGNERoutineJun 10 +28 days
Sold 41,760 shares at $262.82 ($11M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($11M position)0 shares left1x usual sizeFiling
- 6 Form 4 sale BGNERoutineJun 24 +14 days
Sold 2,007 shares at $265.50 ($533k)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($533k position)0 shares left0x usual sizeFiling
- 7 Form 4 sale BGNERoutineSep 8 +441 days
Sold 38,287 shares at $349.10 ($13.4M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($13.4M position)0 shares left0.9x usual sizeFiling
- 8 Form 4 sale BGNERoutineSep 28 +20 days
Sold 31,028 shares at $364.79 ($11.3M)
Wang Xiaodong, Director
10b5-1 planSold 100% of holdings ($11.3M position)0 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (52)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | BGNE | Director | Form 4 sale | 31,028 | $11.3M | 100.0% | Routine | SEC |
| Sep 8, 2026 | BGNE | Director | Form 4 sale | 38,287 | $13.4M | 100.0% | Routine | SEC |
| Jun 24, 2025 | BGNE | Director | Form 4 sale | 2,007 | $533k | 100.0% | Routine | SEC |
| Jun 10, 2025 | BGNE | Director | Form 4 sale | 41,760 | $11M | 100.0% | Routine | SEC |
| May 13, 2025 | BGNE | Director | Form 4 sale | 41,760 | $9.3M | 100.0% | Routine | SEC |
| Apr 14, 2025 | BGNE | Director | Form 4 sale | 41,760 | $10.1M | 100.0% | Routine | SEC |
| Mar 18, 2025 | BGNE | Director | Form 4 sale | 41,760 | $10.9M | 100.0% | Routine | SEC |
| Mar 4, 2025 | BGNE | Director | Form 4 sale | 8,146 | $2.1M | 100.0% | Routine | SEC |
| Feb 4, 2025 | BGNE | Director | Form 4 sale | 41,760 | $9.4M | 100.0% | Routine | SEC |
| Jan 7, 2025 | BGNE | Director | Form 4 sale | 41,760 | $7.4M | 100.0% | Routine | SEC |
| Dec 10, 2024 | BGNE | Director | Form 4 sale | 41,760 | $7.8M | 100.0% | Routine | SEC |
| Dec 10, 2024 | BGNE | Director, Chair, Scientific Advisory Brd | Form 144 notice | 41,760 | $8.7M | Notice | SEC | |
| Nov 26, 2024 | BGNE | Director | Form 4 sale | 48,351 | $9.2M | 100.0% | Routine | SEC |
| Nov 26, 2024 | BGNE | Officer, Chair, Scientific Advisory Brd | Form 144 notice | 7,883 | $1.5M | Notice | SEC | |
| Nov 26, 2024 | BGNE | Director, Chair, Scientific Advisory Brd | Form 144 notice | 40,468 | $7.7M | Notice | SEC | |
| Mar 8, 2023 | BGNE | Director | Form 4 sale | 67,635 | $15.3M | 100.0% | Unusual | SEC |
| Jan 12, 2023 | BGNE | Director | Form 4 sale | 5,000 | $1.3M | 100.0% | Unusual | SEC |
| Jan 11, 2023 | BGNE | Director | Form 4 sale | 5,000 | $1.3M | 100.0% | Unusual | SEC |
| Dec 13, 2022 | BGNE | Director | Form 4 sale | 3,013 | $637k | 100.0% | Unusual | SEC |
| Nov 15, 2022 | BGNE | Director | Form 4 sale | 1,987 | $418k | 100.0% | Unusual | SEC |
| Aug 8, 2022 | BGNE | Director | Form 4 sale | 16,060 | $3.2M | 100.0% | Unusual | SEC |
| Nov 8, 2021 | BGNE | Director | Form 4 sale | 4,500 | $1.6M | 100.0% | Unusual | SEC |
| Nov 8, 2021 | BGNE | Director | Form 4 sale | 4,500 | $1.6M | 100.0% | Unusual | SEC |
| Jul 1, 2021 | BGNE | Director | Form 4 sale | 4,848 | $1.7M | 100.0% | Unusual | SEC |
| May 10, 2021 | BGNE | Director | Form 4 sale | 3,394 | $1M | 100.0% | Unusual | SEC |
| Oct 16, 2020 | BGNE | Director | Form 4 sale | 5,000 | $1.6M | 100.0% | Unusual | SEC |
| Oct 5, 2020 | BGNE | Director | Form 4 sale | 5,000 | $1.5M | 100.0% | Unusual | SEC |
| Sep 25, 2020 | BGNE | Director | Form 4 sale | 5,000 | $1.4M | 100.0% | Unusual | SEC |
| Sep 17, 2020 | BGNE | Director | Form 4 sale | 5,000 | $1.3M | 100.0% | Unusual | SEC |
| Aug 10, 2020 | BGNE | Director | Form 4 sale | 4,000 | $844k | 100.0% | Unusual | SEC |
| Jul 20, 2020 | BGNE | Director | Form 4 sale | 17,000 | $4.3M | 100.0% | Unusual | SEC |
| Jul 7, 2020 | BGNE | Director | Form 4 sale | 6,000 | $1.2M | 100.0% | Unusual | SEC |
| Jul 1, 2020 | BGNE | Director | Form 4 sale | 4,847 | $925k | 100.0% | Unusual | SEC |
| Jun 23, 2020 | BGNE | Director | Form 4 sale | 11,000 | $2M | 100.0% | Unusual | SEC |
| Jun 8, 2020 | BGNE | Director | Form 4 sale | 6,000 | $1M | 100.0% | Unusual | SEC |
| Mar 4, 2020 | BGNE | Director | Form 4 sale | 5,000 | $786k | 100.0% | Unusual | SEC |
| Nov 15, 2019 | BGNE | Director | Form 4 sale | 13,000 | $2.5M | 100.0% | Unusual | SEC |
| Nov 4, 2019 | BGNE | Director | Form 4 sale | 2,000 | $360k | 100.0% | Unusual | SEC |
| Jul 1, 2019 | BGNE | Director | Form 4 sale | 4,847 | $613k | 100.0% | Unusual | SEC |
| Mar 1, 2019 | BGNE | Director | Form 4 sale | 5,000 | $734k | 100.0% | Unusual | SEC |
| Dec 3, 2018 | BGNE | Director | Form 4 sale | 5,000 | $762k | 100.0% | Unusual | SEC |
| Nov 19, 2018 | BGNE | Director | Form 4 sale | 5,000 | $621k | 100.0% | Unusual | SEC |
| Aug 13, 2018 | BGNE | Director | Form 4 sale | 3,449 | $548k | 100.0% | Unusual | SEC |
| Jul 12, 2017 | BGNE | Director | Form 4 sale | 20,000 | $1.4M | 100.0% | Unusual | SEC |
| Jun 28, 2017 | BGNE | Director | Form 4 sale | 35,000 | $1.6M | 63.6% | Unusual | SEC |
| Jun 2, 2017 | BGNE | Director | Form 4 sale | 5,539 | $222k | 9.1% | Plan not stated | SEC |
| May 4, 2017 | BGNE | Director | Form 4 sale | 14,461 | $590k | 19.3% | Plan not stated | SEC |
| Apr 5, 2017 | BGNE | Director | Form 4 sale | 11,650 | $429k | 13.4% | Plan not stated | SEC |
| Mar 24, 2017 | BGNE | Director | Form 4 sale | 38,107 | $1.4M | 30.5% | Unusual | SEC |
| Mar 10, 2017 | BGNE | Director | Form 4 sale | 36,892 | $1.5M | 22.8% | Plan not stated | SEC |
| Feb 27, 2017 | BGNE | Director | Form 4 sale | 38,351 | $1.5M | 19.2% | Plan not stated | SEC |
| Nov 23, 2016 | BGNE | Director | Form 4 sale | 93,750 | $3M | 100.0% | Unusual | SEC |